Rani Therapeutics
RANI
RANI
37 hedge funds and large institutions have $2.01M invested in Rani Therapeutics in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
39% less capital invested
Capital invested by funds: $3.32M → $2.01M (-$1.31M)
Holders
37
Holding in Top 10
2
Calls
$8K
Puts
–
Top Buyers
| 1 | +$158K | |
| 2 | +$56K | |
| 3 | +$53.2K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.5K |
| 5 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$35K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$23.9K | |
| 3 | -$13K | |
| 4 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$7.91K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6.69K |
